共 296 条
[1]
Kuo C-N(2020)Cancers in Taiwan: practical insight from epidemiology, treatments, biomarkers, and cost J Formos Med Assoc 119 1731-41
[2]
Liao Y-M(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries Cancer J Clin 68 394-424
[3]
Kuo L-N(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 E359-86
[4]
Tsai H-J(2017)New insights toward colorectal Cancer chemotherapy using natural bioactive compounds Front Pharmacol 8 109-77
[5]
Chang W-C(2015)Current controversies in the management of metastatic colorectal cancer Cancer Chemother Pharmacol 76 659-75
[6]
Yen Y(2005)Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico dell’Italia Meridionale J Clin Oncol 23 4866-37
[7]
Bray F(2004)FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study J Clin Oncol 22 229-6
[8]
Ferlay J(2007)Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest J Clin Oncol 25 1670-80
[9]
Soerjomataram I(2020)Comprehensive review of targeted therapy for colorectal cancer Signal Transduct Target Ther 5 22-93
[10]
Siegel RL(2019)Colorectal cancer Lancet 394 1467-57947